Wockhardt Limited (NSE:WOCKPHARMA)

India · Delayed Price · Currency is INR

2,152.90

+121.50 (5.98%)

Jun 1, 2026, 3:30 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Pharmaceutical Business	33.73B	30.35B	28.30B	26.57B	32.30B
Pharmaceutical Business Growth	11.14%	7.24%	6.51%	-17.74%	19.28%
Total	33.73B	30.35B	28.30B	26.57B	32.30B
Total Growth	11.14%	7.24%	6.51%	-17.74%	19.28%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
India	6.71B	6.03B	6.09B	6.61B
India Growth	11.28%	-0.99%	-7.87%	55.16%
United States of America	880.00M	1.47B	3.03B	3.42B
United States of America Growth	-40.14%	-51.49%	-11.40%	-22.97%
Europe	15.43B	14.16B	11.84B	16.15B
Europe Growth	8.97%	19.59%	-26.69%	26.07%
Rest of the World	7.10B	6.32B	5.55B	6.12B
Rest of the World Growth	12.34%	13.87%	-9.31%	9.87%
Total	30.12B	27.98B	26.51B	32.30B
Total Growth	7.65%	5.55%	-17.93%	19.28%

Source: S&P Global Market Intelligence.